| Name | (2S,3R,4S,5S,6R)-2-bis(2-chloroethylamino)phosphoryloxy-6-(hydroxymethyl)oxane-3,4,5-triol |
|---|---|
| Synonyms |
β-D-glucosyl-ifosfamide mustard
glc-IPM β-D-Glucopyranose, 1-O-[bis[(2-chloroethyl)amino]phosphinyl]- UNII-1W5N8SZD9A b-D-Glucopyranose 1-(N,N'-Bis(2-chloroethyl)phosphorodiamidate) Glucosylifostamide mustard 1-O-{Bis[(2-chloroethyl)amino]phosphoryl}-β-D-glucopyranose Glufosfamide Glucosyl-ifosfamide mustard |
| Description | Glufosfamide is a novel alkylating agent in which the active metabolite of isophosphoramide mustard is glycosidically linked to β-D-glucose. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 569.9±60.0 °C at 760 mmHg |
| Molecular Formula | C10H21Cl2N2O7P |
| Molecular Weight | 383.163 |
| Flash Point | 298.5±32.9 °C |
| Exact Mass | 382.046356 |
| PSA | 150.32000 |
| LogP | -1.07 |
| Vapour Pressure | 0.0±3.6 mmHg at 25°C |
| Index of Refraction | 1.563 |
|
~91%
132682-98-5 |
| Literature: THRESHOLD PHARMACEUTICALS, INC. Patent: WO2008/11588 A2, 2008 ; Location in patent: Page/Page column 35 ; |